GT Biopharma, Inc. (GTBP)

0.6607 -0.02 (-2.84%) USD  |  NASDAQ  |  Jan 09, 15:04
More

GT Biopharma Long Term Deferred Charges (Quarterly)

Long Term Deferred Charges (Quarterly) Chart

View Long Term Deferred Charges (Quarterly) for GTBP.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Long Term Deferred Charges (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Long Term Deferred Charges (Quarterly) Range, Past 5 Years

View Long Term Deferred Charges (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Long Term Deferred Charges (Quarterly) Benchmarks

View Long Term Deferred Charges (Quarterly) Benchmarks
Start Trial
Regeneron Pharmaceuticals, Inc. --
SELLAS Life Sciences Group, Inc. --
Lyell Immunopharma, Inc. --
Plus Therapeutics, Inc. --
Geron Corp. --